6[2]Guang Yan,Henan Li,Ruhua Zhang,et al.Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets.Drug Deve Ind Pharm,2000,26 (6):681-686. 被引量：1
4Rachel S Meyers,Anita Siu.Pharmacotherapy review of chronic pediatric hypertension[J].Clinical Therapeutics,2011,33(10):1331-1356. 被引量：1
5James R Waller,Derek G.Waller.Drugs for systemic hypertension and angina[J].Medicine,2010,38(8):456–461. 被引量：1
6Takumi Higuma MD,Koichi Oikawa MD,Takeshi Kato MD,et al.Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina:Aomori coronary spastic angina study[J].Journal of Cardiology,2010,56(3):354-360. 被引量：1
7Yunzhen Guo,Jinna Dai,Guiling Qian,et al.Determination of nifedipine in human plasma and its use in bioequivalence study[J].International Journal of Pharmaceutics,2007,341(1/2):91-96. 被引量：1
8Qing-Ri Cao,Jing-Hao Cui,Jun Bom Park,et al.Effect of food components and dosing times on the oral pharmacokinetics of nifedipine in rats[J].International Journal of Pharmaceutics,2010,396(1/2):39-44. 被引量：1
